SCHEMBL6236199

SCHEMBL6236199

ICCCOc1cccc(-c2cnc3nc(-c4cccs4)c(-c4cccs4)nc3c2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KB2 Q9UBS0 7/20 0.41
MAPK1 P28482 8/20 0.37
HSD17B10 Q99714 8/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
TP53 P04637 1/20 0.37
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CASP1 P29466 8/20 0.35
CASP7 P55210 8/20 0.35
CYP1A2 P05177 7/20 0.35
CYP2C9 P11712 7/20 0.35
USP2 O75604 7/20 0.35
ALDH1A1 P00352 7/20 0.35
CYP3A4 P08684 6/20 0.35
TSHR P16473 6/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6240032 0.90 RPS6KB2 (0.42) RPS6KB2MAPK1HSD17B10MEN1KMT2A
SCHEMBL6234238 0.87 RPS6KB2 (0.44) RPS6KB2MAPK1HSD17B10MEN1KMT2A
SCHEMBL6237806 0.87 CHEK2 (0.40) RPS6KB2HSD17B10MEN1KMT2ASMN1; SMN2
SCHEMBL6261584 0.85 RPS6KB2 (0.41) RPS6KB2MAPK1HSD17B10MEN1KMT2A
SCHEMBL6237665 0.82 KMT2A (0.48) KMT2ASMN1; SMN2CYP1A2CYP2C9ALDH1A1
SCHEMBL6233813 0.81 RPS6KB2 (0.43) RPS6KB2MAPK1HSD17B10MEN1KMT2A
SCHEMBL6240919 0.79 RPS6KB2 (0.44) RPS6KB2MAPK1HSD17B10MEN1KMT2A
SCHEMBL6240193 0.78 MAPT (0.51) RPS6KB2CYP2C9CYP3A4SRPK1
SCHEMBL6237136 0.77 RPS6KB2 (0.44) RPS6KB2MAPK1HSD17B10MEN1KMT2A
SCHEMBL6236374 0.77 RPS6KB2 (0.54) RPS6KB2HSD17B10MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005007099-A2 PKB INHIBITORS AS ANTI-TUMOR AGENTS IMCLONE SYSTEMS INCORPORATED (US) 2005-01-27 WO disclosed